Progesterone and Synthetic Progestin Controversies--Reply

JAMA Oncol. 2015 Oct;1(7):987-8. doi: 10.1001/jamaoncol.2015.2294.

Authors

Purna A Joshi¹, Pamela J Goodwin², Rama Khokha¹

Affiliations

¹ Princess Margaret Cancer Centre/University Health Network, Toronto, Ontario, Canada.
² Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada.

PMID: 26448288
DOI: 10.1001/jamaoncol.2015.2294

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Breast Neoplasms / chemically induced*
Estrogen Replacement Therapy / adverse effects*
Estrogens, Conjugated (USP) / adverse effects*
Female
Humans
Medroxyprogesterone Acetate / adverse effects*

Substances

Estrogens, Conjugated (USP)
Medroxyprogesterone Acetate